KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $194.6 million.

  • Opko Health's Cash from Investing Activities fell 2144.45% to $194.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $348.3 million, marking a year-over-year increase of 4834.57%. This contributed to the annual value of $352.2 million for FY2024, which is 203545.44% up from last year.
  • Latest data reveals that Opko Health reported Cash from Investing Activities of $194.6 million as of Q3 2025, which was down 2144.45% from -$2.8 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Cash from Investing Activities registered a high of $247.8 million during Q3 2024, and its lowest value of -$8.8 million during Q2 2021.
  • For the 5-year period, Opko Health's Cash from Investing Activities averaged around $36.5 million, with its median value being -$3.6 million (2023).
  • In the last 5 years, Opko Health's Cash from Investing Activities plummeted by 34330.92% in 2022 and then skyrocketed by 827961.92% in 2024.
  • Quarter analysis of 5 years shows Opko Health's Cash from Investing Activities stood at -$8.7 million in 2021, then increased by 9.3% to -$7.9 million in 2022, then soared by 81.99% to -$1.4 million in 2023, then skyrocketed by 8279.62% to $116.0 million in 2024, then soared by 67.82% to $194.6 million in 2025.
  • Its last three reported values are $194.6 million in Q3 2025, -$2.8 million for Q2 2025, and $40.5 million during Q1 2025.